FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNB...
Saved in:
Published in: | Journal of molecular medicine (Berlin, Germany) Vol. 97; no. 4; pp. 491 - 508 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01-04-2019
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC.
Key messages
• FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials. |
---|---|
AbstractList | Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC. KEY MESSAGES: • FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials. Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC. Key messages • FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials. |
Author | Sener, Elif Funda Taheri, Serpil Delibaşı, Nesrin Nurdinov, Nursultan Donmez-Altuntas, Hamiyet Nalbantoglu, Ufuk Özkul, Yusuf Ozpolat, Bulent Canatan, Halit Hamurcu, Zuhal Tascı, Bayram |
Author_xml | – sequence: 1 givenname: Zuhal surname: Hamurcu fullname: Hamurcu, Zuhal organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center – sequence: 2 givenname: Nesrin surname: Delibaşı fullname: Delibaşı, Nesrin organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University – sequence: 3 givenname: Ufuk surname: Nalbantoglu fullname: Nalbantoglu, Ufuk organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Faculty of Engineering, Department of Computer Engineering, Bioinformatics, Genome and Stem Cell Center – sequence: 4 givenname: Elif Funda surname: Sener fullname: Sener, Elif Funda organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University – sequence: 5 givenname: Nursultan surname: Nurdinov fullname: Nurdinov, Nursultan organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University – sequence: 6 givenname: Bayram surname: Tascı fullname: Tascı, Bayram organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Medical Faculty, Erciyes University – sequence: 7 givenname: Serpil surname: Taheri fullname: Taheri, Serpil organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University – sequence: 8 givenname: Yusuf surname: Özkul fullname: Özkul, Yusuf organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Faculty of Medicine, Department of Medical Genetics, Erciyes University – sequence: 9 givenname: Hamiyet surname: Donmez-Altuntas fullname: Donmez-Altuntas, Hamiyet organization: Faculty of Medicine, Department of Medical Biology, Erciyes University – sequence: 10 givenname: Halit surname: Canatan fullname: Canatan, Halit organization: Faculty of Medicine, Department of Medical Biology, Erciyes University – sequence: 11 givenname: Bulent surname: Ozpolat fullname: Ozpolat, Bulent email: bozpolat@mdanderson.org organization: Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30729279$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kT1v1TAUhi1URG8Lf4ABWWJhMRw7H05GuKIt0kVdQGKzTpyTNJWvE-ykUmb-OA63gMTAYHnw874-9nPBzvzoibGXEt5KAP0uAkioBcht6QJE9YTtZJ4pIfMcztgO6rwUSsvynF3EeA8bVefP2HkGWtVK1zv24-r222fJJ4dr5MjD6IgPnuMyj9Md9itvVj4H9NGGYZqH0aNzKw_ULw7nwff8A1k3eCE5-pYf9hnvyVPcOu6WI_oUHiZHwlOf-AfiTSCMM7foLQVuybn4nD3t0EV68bhfsq9XH7_sb8Th9vrT_v1B2EwXs-i6rmqqQjZWFpLa0qKiti41QQ05yaqkApS0GeYZ1EVlmwYLSxViCbZqrc0u2ZtT7xTG7wvF2RyHuE2AnsYlGqXSr2qlSp3Q1_-g9-MS0uMTJbUGWeoiT5Q6UTaMMQbqzBSGI4bVSDCbInNSZJIi80uRqVLo1WP10hyp_RP57SQB2QmI6cj3FP7e_Z_an2Kuno0 |
CitedBy_id | crossref_primary_10_1016_j_cellsig_2021_109979 crossref_primary_10_1186_s12859_021_04503_y crossref_primary_10_1007_s12282_022_01391_9 crossref_primary_10_2174_1568009623666221228104833 crossref_primary_10_3389_fgene_2021_569318 crossref_primary_10_1007_s11033_022_07536_5 crossref_primary_10_1002_slct_202304893 crossref_primary_10_1007_s12035_023_03609_z crossref_primary_10_1016_j_apsb_2023_08_008 crossref_primary_10_3390_ijms232415699 crossref_primary_10_12677_ACM_2023_131010 crossref_primary_10_3390_cancers11040507 crossref_primary_10_2174_1871520620666200807221047 crossref_primary_10_1080_14728222_2020_1727888 crossref_primary_10_1016_j_canlet_2019_11_014 crossref_primary_10_2174_1871520620666200619180716 crossref_primary_10_2139_ssrn_3970999 crossref_primary_10_1007_s11033_022_07751_0 crossref_primary_10_1007_s11011_022_01125_y crossref_primary_10_1007_s12032_024_02427_0 crossref_primary_10_1038_s41397_022_00297_1 crossref_primary_10_1007_s00408_022_00569_4 crossref_primary_10_36660_abc_20220479 crossref_primary_10_1016_j_lfs_2021_119042 crossref_primary_10_1080_14728222_2023_2177151 crossref_primary_10_1007_s11010_021_04063_y crossref_primary_10_1038_s41418_023_01193_2 crossref_primary_10_1080_08941939_2020_1852344 crossref_primary_10_1093_molehr_gaab030 crossref_primary_10_3390_ijms241813985 crossref_primary_10_1186_s13046_022_02390_6 crossref_primary_10_3389_fonc_2020_626836 |
Cites_doi | 10.1186/s12885-017-3939-4 10.15252/emmm.201708799 10.1007/s00018-018-2759-2 10.1007/s10549-017-4207-7 10.5483/BMBRep.2016.49.8.081 10.1093/abbs/gmv119 10.1111/iep.12187 10.1080/15548627.2015.1100356 10.3892/br.2017.915 10.1002/1873-3468.12594 10.1128/MCB.25.24.10875-10894.2005 10.1016/S0014-5793(01)02915-5 10.2147/CMAR.S34859 10.1016/B978-0-12-407173-5.00004-2 10.1093/jjco/hyt160 10.1038/s41580-018-0003-4 10.1016/j.semcancer 10.1371/journal.pone.0041171 10.3390/cancers9120162 10.3389/fonc.2016.00236 10.1038/onc.2009.282 10.1038/nature11412 10.1007/s12032-013-0475-1 10.1016/j.breast.2017.06.043 10.1007/s10549-016-3904-y 10.1007/s12032-017-0888-3 10.3390/biom8020014 10.1111/his.12002 10.1111/cpr.12402 10.1007/s12192-014-0545-0 10.18632/oncotarget.7672 10.1615/CritRevOncog.2017020575 10.1016/j.canlet.2012.09.017 10.3390/cancers10010018 10.1155/2016/9768183 10.4161/15548627.2014.981788 10.1158/0008-5472.CAN-16-3566 10.1371/journal.pone.0144241 10.1038/sj.bjc.6690012 10.1016/j.ajpath.2013.05.033 10.1097/CAD.0000000000000564 10.4161/15384047.2014.987566 10.1007/s00432-017-2557-5 10.1038/mtna.2013.45 10.18632/oncotarget.23182 |
ContentType | Journal Article |
Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2019 Journal of Molecular Medicine is a copyright of Springer, (2019). All Rights Reserved. |
Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2019 – notice: Journal of Molecular Medicine is a copyright of Springer, (2019). All Rights Reserved. |
DBID | NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s00109-019-01750-8 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed ProQuest One Academic Eastern Edition |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1440 |
EndPage | 508 |
ExternalDocumentID | 10_1007_s00109_019_01750_8 30729279 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: The Scientific and Technological Research Council ?T?B?TAK, Research Fund of the Erciyes University grantid: T?B?TAK- research grant (grant number 214S204) and The Erciyes University (Project number: TDA-2016-6415). |
GroupedDBID | --- -4W -56 -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 36B 4.4 406 408 409 40D 40E 5GY 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAFGU AAHNG AAIAL AAJKR AANZL AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACVWB ACWMK ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEFTE AEGAL AEGNC AEJHL AEJRE AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFKRA AFLOW AFNRJ AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BVXVI CCPQU CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- N9A NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RNS ROL RPX RRX RSV S16 S27 S3A S3B SAP SBL SBY SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TSG TSK TSV TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7R Z7U Z7W Z7Z Z82 Z83 Z87 Z8M Z8O Z8Q Z8T Z8V Z8W Z91 ZMTXR ZOVNA ~EX -Y2 .55 2.D 28- 2P1 2VQ 3O- 3SX 3V. 53G 5QI AACDK AAEOY AAJBT AANXM AAQLM AARHV AASML AAYTO AAYZH ABAKF ABULA ACAOD ACBXY ACDTI ACZOJ ADYPR AEBTG AEFIE AEFQL AEKMD AEMSY AFEXP AFGCZ AGGDS AGJBK AGQEE AGRTI AIGIU AJBLW ALIPV BBWZM CAG COF EMB EMOBN EN4 H13 KOW N2Q NDZJH NPM O9- RIG RNI RZK S1Z S26 S28 SCLPG SV3 T16 WK6 X7M AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c375t-fff8b851bc151ed6ca2ed967e0904e186e5021c3a430958cbba5ce8aa60c8dcc3 |
IEDL.DBID | AEJHL |
ISSN | 0946-2716 |
IngestDate | Fri Oct 25 02:29:22 EDT 2024 Mon Nov 04 11:55:49 EST 2024 Fri Nov 22 00:41:39 EST 2024 Wed Oct 16 00:46:57 EDT 2024 Sat Dec 16 11:59:53 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Beclin-1 FOXM1 Autophagy LC3 Triple-negative breast cancer |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-fff8b851bc151ed6ca2ed967e0904e186e5021c3a430958cbba5ce8aa60c8dcc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30729279 |
PQID | 2177016754 |
PQPubID | 48876 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_2200772267 proquest_journals_2177016754 crossref_primary_10_1007_s00109_019_01750_8 pubmed_primary_30729279 springer_journals_10_1007_s00109_019_01750_8 |
PublicationCentury | 2000 |
PublicationDate | 2019-04-01 |
PublicationDateYYYYMMDD | 2019-04-01 |
PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: New York |
PublicationTitle | Journal of molecular medicine (Berlin, Germany) |
PublicationTitleAbbrev | J Mol Med |
PublicationTitleAlternate | J Mol Med (Berl) |
PublicationYear | 2019 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | PaquetteMEl-HoujeiriLPauseAmTOR pathways in cancer and autophagyCancers (Basel)2018101E1810.3390/cancers100100181:CAS:528:DC%2BC1cXisFKktrbI SabaRAlsayedAZacnyJPDudekAZThe role of Forkhead box protein M1 in breast cancer progression and resistance to therapyInt J Breast Cancer201620161810.1155/2016/97681831:CAS:528:DC%2BC1cXnvFyjt7Y%3D ZhouYRuckerEB3rdZhouBPAutophagy regulation in the development and treatment of breast cancerActa Biochim Biophys Sin Shanghai20164860741:CAS:528:DC%2BC1cXhtVOktr0%3D26637829 GartelALFOXM1 in cancer: interactions and vulnerabilitiesCancer Res2017773135313910.1158/0008-5472.CAN-16-35661:CAS:528:DC%2BC2sXhtVSqu7vF285841825519300 TekedereliIAlpaySNTavaresCDCobanogluZEKaoudTSSahinISoodAKLopez-BeresteinGDalbyKNOzpolatBTargeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancerPLoS One20127e4117110.1371/journal.pone.00411711:CAS:528:DC%2BC38XhtFSkt73P229117543401164 ParmerTGWardMDYurkowEJVyasVHKearneyTJHaitWNActivity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancerBr J Cancer199979596410.1038/sj.bjc.66900121:CAS:528:DyaK1MXmvVKltQ%3D%3D104086942362180 BarsottiAMPrivesCPro-proliferative FoxM1 is a target of p53- mediated repressionOncogene2009284295430510.1038/onc.2009.2821:CAS:528:DC%2BD1MXhtFaju73P197497942898139 ZhongSZhouAQiFLiZYuZLuYLiuXDownregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell lineBiomed Rep20177475010.3892/br.2017.9151:CAS:528:DC%2BC1MXps1yrtA%3D%3D286850595492723 LeeYKLeeJARole of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagyBMB Rep20164942443010.5483/BMBRep.2016.49.8.0811:CAS:528:DC%2BC28XhvFyqtrrK274182835070729 WangICChenYJHughesDPetrovicVMajorMLParkHJTanYAckersonTCostaRHForkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligaseMol Cell Biol200525108751089410.1128/MCB.25.24.10875-10894.20051:CAS:528:DC%2BD2MXhtlektr%2FO163145121316960 MizushimaNThe exponential growth of autophagy-related research: from the humble yeast to the Nobel prizeFEBS Lett201759168168910.1002/1873-3468.125941:CAS:528:DC%2BC2sXjsVSgtLc%3D28186333 KlionskyDJAbdelmohsenKAbeAAbedinMJAbeliovichHAcevedo ArozenaAAdachiHAdamsCMAdamsPDAdeliKAdhihettyPJAdlerSGAgamGAgarwalRAghiMKAgnelloMAgostinisPAguilarPVAguirre-GhisoJAiroldiEMAit-Si-AliSGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy201612122210.1080/15548627.2015.11003562679965226799652 LuXFZengLiangWQChenCFSunSMLinHYFoxM1 is a promising candidate target in the treatment of breast cancerOncotarget2018984285229416660 TekedereliIAlpaySNAkarUYucaEAyugo-RodriguezCHanHDSoodAKLopez-BeresteinGOzpolatBTherapeutic silencing of Bcl-2 by systemically administered siRNA Nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in orthotopic xenograft models of ER (−) and ER (+) breast CancerMol Ther Nucleic Acids20132e12110.1038/mtna.2013.451:CAS:528:DC%2BC3sXhsF2ks7bI240220534028016 ZhangJWangGZhouYChenYOuyangLLiuBMechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapyCell Mol Life Sci2018751803182610.1007/s00018-018-2759-21:CAS:528:DC%2BC1cXisVKjtbY%3D29417176 HamurcuZAshourAKahramanNOzpolatBFOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cellsOncotarget20167166191663510.18632/oncotarget.7672269186064941339 YangHWenLWenMLiuTZhaoLWuBYunYLiuWWangHWangYWenNFoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-met/AKT-dependent positive feedback loopAnti-Cancer Drugs20182921622610.1097/CAD.00000000000005641:CAS:528:DC%2BC2sXhvFOitb%2FF293606625821477 KatohMIgarashiMFukudaHNakagamaHKatohMCancer genetics and genomics of human FOX family genesCancer Lett201332819820610.1016/j.canlet.2012.09.0171:CAS:528:DC%2BC38Xhs1agsLzE23022474 CazzanigaMEAiroldiMArcangeliVArtaleSAtzoriFBallerioAon behalf of; EVA Study GroupEfficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: new insights beyond clinical trials. The EVA studyBreast20173511512110.1016/j.breast.2017.06.0431:STN:280:DC%2BC1cjnvFOktQ%3D%3D28711793 AbbaMCLacunzaEButtiMAldazCMBreast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signaturesBiomark Insights201027103118 HamurcuZDelibaşıNGeçeneSŞenerEFDönmez-AltuntaşHÖzkulYCanatanHOzpolatBTargeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of cyclin-D1 and uPAR/integrin β1/ Src signaling in triple negative breast cancer cellsJ Cancer Res Clin Oncol201814441543010.1007/s00432-017-2557-51:CAS:528:DC%2BC1cXhvVGrtQ%3D%3D29288363 HamurcuZKahramanNAshourAOzpolatBFOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancerBreast Cancer Res Treat201716348549310.1007/s10549-017-4207-71:CAS:528:DC%2BC2sXltl2gtrY%3D28361350 LeungTWLinSSTsangACTongCSChingJCLeungWYOver-expression of FoxM1 stimulates cyclin B1 expressionFEBS Lett2001507596610.1016/S0014-5793(01)02915-51:CAS:528:DC%2BD3MXnslWrt7o%3D11682060 MiyashitaAFukushimaSNakaharaSYamashitaJTokuzumiAAoiJIchiharaAKanemaruHJinninMIhnHInvestigation of FOXM1 as a potential new target for melanomaPLoS One201510e014424110.1371/journal.pone.01442411:CAS:528:DC%2BC28XhsF2rsLk%3D266409504671728 AhmadAWangZKongDAliSLiYBanerjeeSAliRSarkarFHRetraction note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factorsBreast Cancer Res Treat201615860710.1007/s10549-016-3904-y27412558 GartelATargeting FOXM1 auto-regulation in cancerCancer Biol Ther20151618518610.4161/15384047.2014.9875661:CAS:528:DC%2BC2MXhvVWqtL7L256034264622879 YeXZhangYHeBMengYLiYGaoYQuantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migrationInt J Clin Exp Pathol2015815836158441:CAS:528:DC%2BC1cXnslansr0%3D268848544730067 SongXFiati KenstonSSZhaoJYangDGuYRoles of FoxM1 in cell regulation and breast cancer targeting therapyMed Oncol2017344110.1007/s12032-017-0888-31:CAS:528:DC%2BC2sXitlKqtr4%3D28176242 ZhaoHYangMZhaoJWangJZhangYZhangQHigh expression of LC3B is associated with progression and poor outcome in triple-negative breast cancerMed Oncol20133047510.1007/s12032-013-0475-11:CAS:528:DC%2BC3sXjsVylur8%3D23371253 LefortSJoffreCKiefferYGivelAMBourachotBZagoGBiecheIDuboisTMeseureDVincent-SalomonACamonisJMechta-GrigoriouFInhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancersAutophagy2014102122214210.4161/15548627.2014.9817881:CAS:528:DC%2BC2MXmtlSns7o%3D25427136 EngebraatenOVollanHKMBørresen-DaleALTriple-negative breast cancer and the need for new therapeutic targetsAm J Pathol20131831064107410.1016/j.ajpath.2013.05.0331:CAS:528:DC%2BC3sXhsV2ktrjP23920327 The Cancer Genome Atlas NetworkComprehensive molecular portraits of human breast tumoursNature2013490617010.1038/nature11412 WierstraIThe transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological rolesAdv Cancer Res20131189739810.1016/B978-0-12-407173-5.00004-21:CAS:528:DC%2BC3sXhtlSqurzJ23768511 SunDZhuLZhaoYJiangYChenLYuYOuyangLFluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancerCell Prolif201851e1240210.1111/cpr.124021:CAS:528:DC%2BC1cXlvFGqtL4%3D29094413 NarrandesSHuangSMurphyLXuWThe exploration of contrasting pathways in triple negative breast cancer (TNBC)BMC Cancer2018182210.1186/s12885-017-3939-41:CAS:528:DC%2BC1cXisFWnu77F293015065753474 DengQWangZWangLZhangLXiangXWangZChongTLower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinomaJpn J Clin Oncol2013431261126810.1093/jjco/hyt16024186908 KusuzakiKMatsubaraTSatonakaHMatsumineANakamuraTSudoAMurataHHosogiSBaldiniNIntraoperative photodynamic surgery (iPDS) with Acridine Orange for musculoskeletal sarcomasCureus20146e204 CivilettoGDoganSACeruttiRFagiolariGMoggioMLampertiCBenincáCViscomiCZevianiMRapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesisEMBO Mol Med20181011e879910.15252/emmm.2017087991:CAS:528:DC%2BC1cXhvV2jur7F303098556220341 TangDYEllisRALovatPEPrognostic impact of autophagy biomarkers for cutaneous melanomaFront Oncol2016623610.3389/fonc.2016.00236278823085101199eCollection YangXShiYYanJFanHDownregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cellsAm J Transl Res2018106296381:CAS:528:DC%2BC1MXhtlOku77F295114575835828 Nandi D, Cheema PS, Jaiswal N, Nag A (2017) FoxM1: repurposing an oncogene as a biomarker. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer ZhuHYangXLiuJZhouLZhangCXuLQinQZhanLLuJChengHSunXEukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cellsCell Stress Chaperones20152021722010.1007/s12192-014-0545-01:CAS:528:DC%2BC2cXhs1Ohsr3L25248493 WangXXieJChristopherGProud. Eukaryotic elongation factor 2 kinase (eEF2K) in cancerCancers (Basel)2017916210.3390/cancers91201621:CAS:528:DC%2BC1cXisV2isrjO MrakovcicMFröhlichLFp53-mediated molecular control of autophagy in tumor cellsBiomolecules20188E1410.3390/biom80200141:CAS:528:DC%2BC1cXhvFWmsb7N29561758 DreosRAmbrosiniGPérierRCBucherPThe eukaryotic promoter database: expansion of EPDnew and new promoter analysis t Z Hamurcu (1750_CR21) 2017; 163 I Tekedereli (1750_CR42) 2012; 7 I Dikic (1750_CR47) 2018; 19 X Wang (1750_CR20) 2017; 9 JJ Lee (1750_CR30) 2016; 97 1750_CR44 S Narrandes (1750_CR2) 2018; 18 G Civiletto (1750_CR29) 2018; 10 R Saba (1750_CR50) 2016; 2016 W Guo (1750_CR4) 2017; 22 A Ahmad (1750_CR13) 2016; 158 XF Lu (1750_CR8) 2018; 9 R Dreos (1750_CR25) 2014; 43 X Yang (1750_CR10) 2018; 10 Y Zhou (1750_CR16) 2016; 48 AL Gartel (1750_CR46) 2017; 77 Z Hamurcu (1750_CR14) 2016; 7 BY Fei (1750_CR12) 2017; 14 H Zhu (1750_CR26) 2015; 20 N Mizushima (1750_CR17) 2017; 591 B Ozpolat (1750_CR15) 2015; 7 Z Hamurcu (1750_CR19) 2018; 144 DJ Klionsky (1750_CR31) 2016; 12 TW Leung (1750_CR34) 2001; 507 H Yang (1750_CR11) 2018; 29 The Cancer Genome Atlas Network (1750_CR7) 2013; 490 I Tekedereli (1750_CR24) 2013; 2 MC Abba (1750_CR6) 2010; 27 S Lefort (1750_CR43) 2014; 10 AM Barsotti (1750_CR33) 2009; 28 I Wierstra (1750_CR37) 2013; 118 DY Tang (1750_CR18) 2016; 6 M Katoh (1750_CR36) 2013; 328 H Zhao (1750_CR38) 2013; 30 ME Cazzaniga (1750_CR3) 2017; 35 O Engebraaten (1750_CR5) 2013; 183 M Mrakovcic (1750_CR48) 2018; 8 TG Parmer (1750_CR27) 1999; 79 S Zhong (1750_CR40) 2017; 7 A Gartel (1750_CR45) 2015; 16 X Song (1750_CR9) 2017; 34 M Paquette (1750_CR28) 2018; 10 K Kusuzaki (1750_CR23) 2014; 6 IC Wang (1750_CR35) 2005; 25 A Miyashita (1750_CR51) 2015; 10 1750_CR1 X Ye (1750_CR32) 2015; 8 J Choi (1750_CR39) 2013; 62 D Sun (1750_CR41) 2018; 51 YK Lee (1750_CR49) 2016; 49 J Zhang (1750_CR52) 2018; 75 Q Deng (1750_CR22) 2013; 43 |
References_xml | – volume: 18 start-page: 22 year: 2018 ident: 1750_CR2 publication-title: BMC Cancer doi: 10.1186/s12885-017-3939-4 contributor: fullname: S Narrandes – volume: 10 start-page: e8799 issue: 11 year: 2018 ident: 1750_CR29 publication-title: EMBO Mol Med doi: 10.15252/emmm.201708799 contributor: fullname: G Civiletto – volume: 75 start-page: 1803 year: 2018 ident: 1750_CR52 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-018-2759-2 contributor: fullname: J Zhang – volume: 163 start-page: 485 year: 2017 ident: 1750_CR21 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4207-7 contributor: fullname: Z Hamurcu – volume: 49 start-page: 424 year: 2016 ident: 1750_CR49 publication-title: BMB Rep doi: 10.5483/BMBRep.2016.49.8.081 contributor: fullname: YK Lee – volume: 48 start-page: 60 year: 2016 ident: 1750_CR16 publication-title: Acta Biochim Biophys Sin Shanghai doi: 10.1093/abbs/gmv119 contributor: fullname: Y Zhou – volume: 97 start-page: 170 year: 2016 ident: 1750_CR30 publication-title: Int J Exp Pathol doi: 10.1111/iep.12187 contributor: fullname: JJ Lee – volume: 6 start-page: e204 year: 2014 ident: 1750_CR23 publication-title: Cureus contributor: fullname: K Kusuzaki – volume: 12 start-page: 1 year: 2016 ident: 1750_CR31 publication-title: Autophagy doi: 10.1080/15548627.2015.1100356 contributor: fullname: DJ Klionsky – volume: 7 start-page: 47 year: 2017 ident: 1750_CR40 publication-title: Biomed Rep doi: 10.3892/br.2017.915 contributor: fullname: S Zhong – ident: 1750_CR1 – volume: 591 start-page: 681 year: 2017 ident: 1750_CR17 publication-title: FEBS Lett doi: 10.1002/1873-3468.12594 contributor: fullname: N Mizushima – volume: 25 start-page: 10875 year: 2005 ident: 1750_CR35 publication-title: Mol Cell Biol doi: 10.1128/MCB.25.24.10875-10894.2005 contributor: fullname: IC Wang – volume: 507 start-page: 59 year: 2001 ident: 1750_CR34 publication-title: FEBS Lett doi: 10.1016/S0014-5793(01)02915-5 contributor: fullname: TW Leung – volume: 7 start-page: 291 year: 2015 ident: 1750_CR15 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S34859 contributor: fullname: B Ozpolat – volume: 118 start-page: 97 year: 2013 ident: 1750_CR37 publication-title: Adv Cancer Res doi: 10.1016/B978-0-12-407173-5.00004-2 contributor: fullname: I Wierstra – volume: 43 start-page: 1261 year: 2013 ident: 1750_CR22 publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyt160 contributor: fullname: Q Deng – volume: 19 start-page: 349 year: 2018 ident: 1750_CR47 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-018-0003-4 contributor: fullname: I Dikic – ident: 1750_CR44 doi: 10.1016/j.semcancer – volume: 7 start-page: e41171 year: 2012 ident: 1750_CR42 publication-title: PLoS One doi: 10.1371/journal.pone.0041171 contributor: fullname: I Tekedereli – volume: 27 start-page: 103 year: 2010 ident: 1750_CR6 publication-title: Biomark Insights contributor: fullname: MC Abba – volume: 9 start-page: 162 year: 2017 ident: 1750_CR20 publication-title: Cancers (Basel) doi: 10.3390/cancers9120162 contributor: fullname: X Wang – volume: 6 start-page: 236 year: 2016 ident: 1750_CR18 publication-title: Front Oncol doi: 10.3389/fonc.2016.00236 contributor: fullname: DY Tang – volume: 8 start-page: 15836 year: 2015 ident: 1750_CR32 publication-title: Int J Clin Exp Pathol contributor: fullname: X Ye – volume: 28 start-page: 4295 year: 2009 ident: 1750_CR33 publication-title: Oncogene doi: 10.1038/onc.2009.282 contributor: fullname: AM Barsotti – volume: 490 start-page: 61 year: 2013 ident: 1750_CR7 publication-title: Nature doi: 10.1038/nature11412 contributor: fullname: The Cancer Genome Atlas Network – volume: 30 start-page: 475 year: 2013 ident: 1750_CR38 publication-title: Med Oncol doi: 10.1007/s12032-013-0475-1 contributor: fullname: H Zhao – volume: 35 start-page: 115 year: 2017 ident: 1750_CR3 publication-title: Breast doi: 10.1016/j.breast.2017.06.043 contributor: fullname: ME Cazzaniga – volume: 158 start-page: 607 year: 2016 ident: 1750_CR13 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-016-3904-y contributor: fullname: A Ahmad – volume: 34 start-page: 41 year: 2017 ident: 1750_CR9 publication-title: Med Oncol doi: 10.1007/s12032-017-0888-3 contributor: fullname: X Song – volume: 8 start-page: E14 year: 2018 ident: 1750_CR48 publication-title: Biomolecules doi: 10.3390/biom8020014 contributor: fullname: M Mrakovcic – volume: 62 start-page: 275 year: 2013 ident: 1750_CR39 publication-title: Histopathology doi: 10.1111/his.12002 contributor: fullname: J Choi – volume: 51 start-page: e12402 year: 2018 ident: 1750_CR41 publication-title: Cell Prolif doi: 10.1111/cpr.12402 contributor: fullname: D Sun – volume: 20 start-page: 217 year: 2015 ident: 1750_CR26 publication-title: Cell Stress Chaperones doi: 10.1007/s12192-014-0545-0 contributor: fullname: H Zhu – volume: 7 start-page: 16619 year: 2016 ident: 1750_CR14 publication-title: Oncotarget doi: 10.18632/oncotarget.7672 contributor: fullname: Z Hamurcu – volume: 22 start-page: 427 year: 2017 ident: 1750_CR4 publication-title: Crit Rev Oncog doi: 10.1615/CritRevOncog.2017020575 contributor: fullname: W Guo – volume: 328 start-page: 198 year: 2013 ident: 1750_CR36 publication-title: Cancer Lett doi: 10.1016/j.canlet.2012.09.017 contributor: fullname: M Katoh – volume: 14 start-page: 6553 year: 2017 ident: 1750_CR12 publication-title: Oncol Lett contributor: fullname: BY Fei – volume: 10 start-page: E18 issue: 1 year: 2018 ident: 1750_CR28 publication-title: Cancers (Basel) doi: 10.3390/cancers10010018 contributor: fullname: M Paquette – volume: 10 start-page: 629 year: 2018 ident: 1750_CR10 publication-title: Am J Transl Res contributor: fullname: X Yang – volume: 2016 start-page: 1 year: 2016 ident: 1750_CR50 publication-title: Int J Breast Cancer doi: 10.1155/2016/9768183 contributor: fullname: R Saba – volume: 10 start-page: 2122 year: 2014 ident: 1750_CR43 publication-title: Autophagy doi: 10.4161/15548627.2014.981788 contributor: fullname: S Lefort – volume: 77 start-page: 3135 year: 2017 ident: 1750_CR46 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-3566 contributor: fullname: AL Gartel – volume: 10 start-page: e0144241 year: 2015 ident: 1750_CR51 publication-title: PLoS One doi: 10.1371/journal.pone.0144241 contributor: fullname: A Miyashita – volume: 43 start-page: D92 issue: Database issue year: 2014 ident: 1750_CR25 publication-title: Nucleic Acids Res contributor: fullname: R Dreos – volume: 79 start-page: 59 year: 1999 ident: 1750_CR27 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6690012 contributor: fullname: TG Parmer – volume: 183 start-page: 1064 year: 2013 ident: 1750_CR5 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2013.05.033 contributor: fullname: O Engebraaten – volume: 29 start-page: 216 year: 2018 ident: 1750_CR11 publication-title: Anti-Cancer Drugs doi: 10.1097/CAD.0000000000000564 contributor: fullname: H Yang – volume: 16 start-page: 185 year: 2015 ident: 1750_CR45 publication-title: Cancer Biol Ther doi: 10.4161/15384047.2014.987566 contributor: fullname: A Gartel – volume: 144 start-page: 415 year: 2018 ident: 1750_CR19 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-017-2557-5 contributor: fullname: Z Hamurcu – volume: 2 start-page: e121 year: 2013 ident: 1750_CR24 publication-title: Mol Ther Nucleic Acids doi: 10.1038/mtna.2013.45 contributor: fullname: I Tekedereli – volume: 9 start-page: 842 year: 2018 ident: 1750_CR8 publication-title: Oncotarget doi: 10.18632/oncotarget.23182 contributor: fullname: XF Lu |
SSID | ssj0017594 |
Score | 2.5154145 |
Snippet | Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets.... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 491 |
SubjectTerms | Autophagy Biomedical and Life Sciences Biomedicine Breast cancer Cell survival Chromatin Clinical trials Drug resistance Forkhead protein Human Genetics Immunoprecipitation Internal Medicine Medical prognosis Molecular Medicine Molecular modelling Original Article Phagocytosis Proteins Rapamycin Starvation Therapeutic applications Transcription Tumorigenesis |
Title | FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells |
URI | https://link.springer.com/article/10.1007/s00109-019-01750-8 https://www.ncbi.nlm.nih.gov/pubmed/30729279 https://www.proquest.com/docview/2177016754 https://search.proquest.com/docview/2200772267 |
Volume | 97 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtNAcNSHVHEBSnkYWjRI3GBR4n05x1ISAmrhQCv1Zq13N1FF5FZ5HHLmx5nZ2Eao5UAPlg9ej9c7s_PYeQG8JZowQUstYu6UUJoMlIoDbJQxIXeEdZWq7Y9_2G-Xxachl8mR3dFF_fND65FMjLrLdUtOHLJ8-SIxJ4pt2CXZo4m4d4-HX8ennfPA6tT_kAwXI3KyB5pcmbuh_C2PbimZtxykSe6MHt1rxo_hYaNm4vGGLvZhK9ZPYO-scaQfwK_R98uzPt7M3HqBDjnGEK9qdCuuM-Cma6zWuGQx1jIVN5utcb5pXE-TwI-RcypFH10d8PRE4pSZJsNIXf_oZT7BF3WcpsriWHHw-xI9E9kc2V2weAoXo-H5yVg0_RiEl1YvxWQyKSrS0CpPakIMxrs8hoGxsTfoqdgvTNSkMXjplCTFrfBV5bSPhXOm54vgvXwGO_V1HV8A5hNaFmIXpB4GZSs5UN6HaPJIHIHEtszgXYuV8mZTdqPsCiyndS0JQJnWtSwyOGwRVzZbcFGSrWU5x0KrDN50j2nz8C-6Ol6vaAyf1FrSQG0GzzcI7z4nuaZ6bgcZvG_R-wf4v-fy8v-Gv4IHeaIQjgU6hJ3lfBWPYHsRVq8bsub7l_PPo9-v5fCa |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RVoJeeJeGFhgkbmBpN3bs5NiWLluxWw4sUm-RY3tXSKu02sdhz_3jnfEmQahwgENOSRzHM575xvMC-EA8oX0mMxFSq4TKyECpOMBGae1TS1RXsdr-8Lu5vMo_n3OZHNXmwsRo99YlGSV1l-wWvThk-vJFek7kO7CnCq2Il_dOLiZfBp33wGSxASJZLlqkZBA0yTJ_HuV3hXQPZd7zkEbFM3jyf1N-Co8boIknW854Bg9C_RwejhtX-gu4HXy7GvfxZm43S7TIUYb4s0a75koDdrbBaoMrVmStWLHz-QYX29b1NAk8DZxVKfpoa4-jM4kzFps8Ruz7Ry_zGb6owyzWFseKw99X6JjNFsgOg-VL-DE4n5wNRdORQThpspWYTqd5RRitcgQUgtfOpsEX2oRe0VOhn-uQEWZw0ipJ0C13VWUzF3Jrdc_l3jl5ALv1dR0OAdMpLQsJDAKIXplKFso5H3QaSCaQ4pYJfGzJUt5sC2-UXYnluK4lDVDGdS3zBI5bypXNJlyWZG0ZzrLIVALvu9u0ffgXbR2u1_QMn9UawqAmgVdbinefk1xVPTVFAp9a8v4a_O9zef1vj7-DR8PJeFSOLi6_HsF-GrmFI4OOYXe1WIc3sLP067cNj98Bld_y_A |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RVqq4QGmhDbTUlXoDq7uxY2ePfexqC9uCBEi9RY7trCqt0tVu9rBn_jgzzgOhwqHikFOSieMZe77xvABOUSaUS0TCfWwklwkaKDkF2EilXGyQ6zJU2x9_07d36dWQyuR0Wfwh2r11SdY5DVSlqazO5q446xLfgkcHzWC6UOfxdAO2JFoyKOlb58NP40nnSdBJaIaIVoziMRoHTeLM36n8qZweIc5H3tKghEYv_3_4O_CiAaDsvJaYV_DMl7uwfdO42Pfg5-jL3U2fzWdmvWSGUfQhuy-ZWVEFAjNds3zNKlJw7XZjZrM1W9Qt7XFA7MJTtiXvM1M6NrkUbErbKdEI_QDxZTrb56WfhprjLKew-IpZEr8FI0fC8jX8GA2_X45506mBW6GTihdFkeaI3XKLAMI7ZU3s3UBp3xv0pO-nyieIJawwUiCkS22em8T61BjVs6mzVryBzfKh9AfA4gKnBTcSBI5O6lwMpLXOq9jjXoEKXUTwoWVRNq8LcmRd6eUwrxkSyMK8ZmkEhy0Xs2ZxLjO0wjRlXyQygpPuNi4r-kVT-ocVPkNnuBqxqY5gv-Z-9zlB1dZjPYjgY8vq38T_PZa3T3v8GLa_Xo2yyfXt53fwPA7CQgFDh7BZLVb-CDaWbvW-EfdfuDT7vw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FOXM1+plays+a+role+in+autophagy+by+transcriptionally+regulating+Beclin-1+and+LC3+genes+in+human+triple-negative+breast+cancer+cells&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Hamurcu%2C+Zuhal&rft.au=Deliba%C5%9F%C4%B1%2C+Nesrin&rft.au=Nalbantoglu%2C+Ufuk&rft.au=Sener%2C+Elif+Funda&rft.date=2019-04-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0946-2716&rft.eissn=1432-1440&rft.volume=97&rft.issue=4&rft.spage=491&rft.epage=508&rft_id=info:doi/10.1007%2Fs00109-019-01750-8&rft.externalDocID=10_1007_s00109_019_01750_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon |